The latest coronavirus stories



Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues


While approval seems to be a foregone conclusion, there’s not much parents or vaccine providers can do until authorization from federal regulators comes. But plans are in the works on many fronts to offer the vaccine to those who want it.





U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially